 SEATTLE, Jan. 03, 2023 GLOBE NEWSWIRE -- Chinook Therapeutics, Inc. Nasdaq: KDNY, a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2023 at 11:15 am EST, and participate in 1x1 meetings. 